S – Decisions at the annual general meeting 2015

DGAP-News: Exiqon A/S

2015-03-19 / 16:15

---------------------------------------------------------------------

Copenhagen, 2015-03-19 16:15 CET (GLOBE NEWSWIRE) -- The annual general meeting
of Exiqon A/S was held today, 19 March 2015, at the Company's address,
Skelstedet 16, DK-2950 Vedbæk, where the general meeting resolved: 

1.                 To adopt the audited annual report.

2.                 To appropriate the result of the year as proposed in the
audited annual report. 

3.                 To approve the supervisory board's remuneration for 2015 as
proposed by the supervisory 
                    board.

4.                 To re-elect Thorleif Krarup, Erik Walldén, Michael Nobel and
Per Wold-Olsen as members 
                    of the company's supervisory board.

5.                 To elect Rodney Turner as a new member of the company's
supervisory board. 

6.                 To appoint KPMG Statsautoriseret Revisionspartnerselskab as
the company's new auditor. 

7.                 To delete the maximum age for members of the supervisory
board in the articles of 
                    association.

8.                 To authorize the supervisory board to issue warrants without
pre-emption rights for the 
                    company's shareholders and to implement the corresponding
capital increases with a right 
                    to subscribe to up to a nominal amount of DKK 3,687,408
shares, however not exceeding 
                    10% of the issued nominal share capital from time to time
and to re-apply or re-issue any 
                    lapsed or non-exercised warrants.

9.                To authorize the chairman of the meeting to make amendments
and additions to the 
                   resolutions adopted in connection with registration thereof.

At a supervisory board meeting held immediately after the general meeting, the
supervisory board elected Erik Walldén as chairman of the supervisory board and
Thorleif Krarup as vice chairman of the supervisory board. The composition of
the supervisory board is as follows: 

Erik Walldén, chairman
Thorleif Krarup, vice chairman
Michael Nobel
Per Wold-Olsen
Rodney Turner

Additional information
Lars Kongsbak, CEO, tel. +45 4566 0888 (cell: +45 4090 2101)
Hans Henrik Chrois Christensen, CFO, tel. +45 4566 0888 (cell: +45 4090 2131)

About Exiqon (for the media)
Exiqon operates in two business areas: Exiqon Life Sciences is a leading
provider of flexible solutions for RNA analysis used by academia, biotech and
pharmaceutical companies around the world to make ground breaking discoveries
about the correlation between gene activity and the development of cancer and
other diseases. Exiqon Diagnostics develops novel molecular diagnostic tests
for early detection of cancer and treatment selection for patients based on
gene activity analysis, using the tools developed by Exiqon Life Sciences.
Exiqon is listed on the NASDAQ in Copenhagen. For more information about us,
please visit www.exiqon.com
News Source: NASDAQ OMX



---------------------------------------------------------------------

2015-03-19 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English       
Company:     Exiqon A/S    
 
 
             Denmark       
ISIN:        DK0060077758  
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
335233 2015-03-19